-       Report 
- May 2025
-  560 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
            -       Report 
- April 2025
-  138 Pages 
- Global 
   From       €2280EUR$2,549USD£2,006GBP 
      €2682EUR$2,999USD£2,360GBP 
            -       Report 
- October 2025
-  186 Pages 
- Global 
   From       €3171EUR$3,545USD£2,789GBP 
      €3523EUR$3,939USD£3,099GBP 
          -       Report 
- October 2025
-  413 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
          -       Report 
- September 2025
-  250 Pages 
- Global 
   From       €4016EUR$4,490USD£3,533GBP 
             -       Report 
- August 2025
-  149 Pages 
- Global 
   From       €3533EUR$3,950USD£3,108GBP 
          -       Report 
- June 2025
-  250 Pages 
- United States 
   From       €2495EUR$2,789USD£2,194GBP 
          -       Report 
- January 2025
-  165 Pages 
- Global 
   From       €4159EUR$4,650USD£3,659GBP 
          -       Report 
- August 2025
-  150 Pages 
- Global 
   From       €5322EUR$5,950USD£4,681GBP 
          -       Report 
- October 2025
-  283 Pages 
- Global 
   From       €5233EUR$5,850USD£4,603GBP 
            -       Report 
- March 2025
-  142 Pages 
- Global 
   From       €3687EUR$4,123USD£3,244GBP 
      €4338EUR$4,850USD£3,816GBP 
          -       Report 
- May 2025
-  300 Pages 
- Global 
   From       €3573EUR$3,995USD£3,143GBP 
          -       Report 
- October 2025
-  307 Pages 
- Global 
   From       €6257EUR$6,995USD£5,504GBP 
          -       Report 
- October 2025
-  594 Pages 
- Global 
   From       €6257EUR$6,995USD£5,504GBP 
          -       Report 
- March 2025
-  309 Pages 
- Global 
   From       €4024EUR$4,499USD£3,540GBP 
          -       Report 
- March 2025
-  331 Pages 
- Global 
   From       €4292EUR$4,799USD£3,776GBP 
          -       Report 
- August 2025
-  393 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
          -       Report 
- June 2025
-  325 Pages 
- Global 
   From       €4428EUR$4,950USD£3,895GBP 
          -       Report 
- January 2025
-  165 Pages 
- Global 
   From       €2549EUR$2,850USD£2,242GBP 
          -       Report 
- September 2025
-  125 Pages 
- Global 
   From       €4159EUR$4,650USD£3,659GBP 
       
       The Biomarkers market is a sector of the healthcare industry that focuses on the development and use of biomarkers for the diagnosis, prognosis, and treatment of diseases. Biomarkers are biological molecules that can be used to measure the presence or absence of a disease, or to monitor the progression of a disease. They can also be used to predict the response to a particular treatment. Biomarkers are typically proteins, nucleic acids, or metabolites that are found in the body and can be measured    in a variety of ways.
Biomarkers are used in a variety of medical applications, including cancer diagnosis and treatment, cardiovascular disease, and neurological disorders. They are also used in drug development, to identify potential drug targets and to monitor the safety and efficacy of drugs.
Some of the major companies in the Biomarkers market include Abbott Laboratories, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Merck, Novartis, Pfizer, Roche, and Sanofi. Show Less   Read more